Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.
Apr 3, 2013
By:
Patricia Van Arnum
Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.
|
The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.
Apr 3, 2013
By:
Patricia Van Arnum
The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.
|
Ruling has implications for intellectual property protection for innovator drugs in India.
Apr 3, 2013
By:
Patricia Van Arnum
Ruling has implications for intellectual property protection for innovator drugs in India.
|
Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations.
Apr 2, 2013
By:
Patricia Van Arnum
Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations.
|
Apr 2, 2013
By:
Patricia Van Arnum
Novartis loses an appeal in seeking patent protection in India for its anticancer drug.
|
Contract API manufacturers proceed with select investment in capacity and service additions.
Apr 2, 2013
By:
Patricia Van Arnum
Contract API manufacturers proceed with select investment in capacity and service additions.
|
Supply-demand fundamentals show strong growth for generic APIs as gains in innovator APIs lag.
Mar 6, 2013
By:
Patricia Van Arnum
Supply-demand fundamentals show strong growth for generic APIs as gains in innovator APIs lag.
|
Contract API manufacturers and fine-chemical producers proceed with select investment in capacity and service additions.
Mar 6, 2013
By:
Patricia Van Arnum
Contract API manufacturers and fine-chemical producers proceed with select investment in capacity and service additions.
|
Incremental innovation advances medicines by expanding therapeutic classes, increasing the number of available dosing options, discovering new physiological interactions of known medicines, and improving other properties of existing medicines.
Mar 6, 2013
By:
Patricia Van Arnum
Incremental innovation advances medicines by expanding therapeutic classes, increasing the number of available dosing options, discovering new physiological interactions of known medicines, and improving other properties of existing medicines
|
|
